NeuroSense Therapeutics Ltd. (NRSN)
NCM – Real vaqt narxi. Valyuta: USD
0.83
-0.00 (-0.24%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
0.83
-0.00 (-0.24%)
Yopilishda: May 12, 2026, 4:00 PM EDT
NeuroSense Therapeutics Ltd., klinik bosqichdagi biotexnologik kompaniya, Amerika Qo'shma Shtatlarida va xalqaro miqyosda nevrodegenerativ kasalliklardan aziyat chekayotgan bemorlar uchun davolash usullarini kashf etish va ishlab chiqishga qaratilgan. Kompaniyaning asosiy mahsuloti PrimeC hisoblanadi, bu siprofloksatsin va seleykoksibning doimiy dozali kombinatsiyasining uzaytirilgan-relizli og'iz orqali qabul qilinadigan shakli bo'lib, hozirda amiotrofik lateral sklerozni davolash uchun 2b/3 bosqichli klinik sinovlardan o'tmoqda va Altsgeymer kasalligini davolash uchun 2-bosqichli klinik sinovlarni tugatgan, shuningdek, Parkinson kasalligini davolash uchun preklinik tadqiqotlarda. Uning preklinik dasturi Parkinson kasalligini davolash uchun StabiliC va Altsgeymer kasalligini davolash uchun CogniCni o'z ichiga oladi. NeuroSense Therapeutics Ltd. 2017-yilda tashkil etilgan va uning shtab-kvartirasi Isroilning Xertzliya shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Niva Russek-Blum Ph.D. | Chief Technology Officer |
| Mr. Alon Ben-Noon | Co-Founder, CEO & Director |
| Mr. Or Eisenberg | Chief Financial Officer |
| Ms. Keren Pushett | Head of HR |
| Ms. Yael Barak | VP of Quality & Compliance |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-28 | 6-K | ea0288103-6k_neurosense.htm |
| 2026-04-24 | 6-K | ea0287630-6k_neurosense.htm |
| 2026-04-06 | 6-K | ea0285169-6k_neuro.htm |
| 2026-03-31 | 20-F | ea0283072-20f_neurosense.htm |
| 2026-03-24 | 6-K | ea0283188-6k_neurosense.htm |
| 2026-03-16 | 6-K | ea0281799-6k_neuro.htm |
| 2026-03-11 | 6-K | ea0280853-6k_neurosense.htm |
| 2026-02-18 | 6-K | ea0277495-6k_neuro.htm |
| 2026-02-13 | 6-K | ea0276620-6k_neuro.htm |
| 2026-02-09 | 6-K | ea0276115-6k_neurosense.htm |